Downloading...
Download

Psychedelic

ATAI Life Sciences | ATAI | Long at $1.30ATAI Life Sciences NASDAQ:ATAI , a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, is fast approaching my selected historical simple moving average (SMA). Often, but not always, the closer the price gets to this line, the higher chance there is for a fast upward move. In anticipation of this move, NASDAQ:ATAI is in a personal buy zone at $1.30. A word of caution: this is a pure technical analysis play and this company is not expected to be profitable for many, many years... Target #1 = $1.75 Target #2 = $2.50 Target #3 = $2.95
NASDAQ:ATAILong
by WorthlessViews
2
Deeply oversold/undervalued psychedelics playPsychedelics space has seen some multi-baggers in the span of the last 2 weeks, suggesting investors are once again starting to pour money into speculative shroom stocks. CSE:LVT is deeply oversold (RSI @ 22.69), hitting all time lows. The company is deeply fundamentally undervalued: - $1.87M market cap - Raised $1.5M at 0.20 in February - Generating revenue of over $2M per quarter Some comparable psychedelic companies with less revenue are trading at more than 10x. Unless there's some kind of fundamental/unknown reason for recent selloff, other than weak general markets, this is a potential multi-bagger candidate from current levels, in my humble opinion. GLTA
CSE:LVTLong
by agstockpicks
psychedelic is the future for mental healthpsychedelic is the future for mental health. I don't understand why the chart doesn't move but it will be because nothing else can heal the mental illness. At this moment we only have 20 years of Internet. We need to go forward. Psychotherapy doesn't work because sometimes even the client doesn't know what he have. I don't say that compass pathway will be the winner but psychedelic will be. Can you be mindmed medicine, ataiI life science or compass pathway , they are the most biggest market cap in the stock market right now in they category.
NASDAQ:CMPSLong
by CharlesGhavidia
MNMD ScenarioThis is a biased opinion as I truly believe the Psychedelic stock market will be expanding more and more in the years to come. Hence my long term bullish approach. Mindmed has been in a downtrend since Q3 21. Early February, price was rejected at yearly open. I do not think this reflects the company value but rather a market sentiment. Earnings early march might give some volume. Investment thesis is as follow: I want to support companies that are working towards a better understanding of mental health issues, but I want my support to be as efficient as possible considering the economic uncertainties that surrounds the global market. Either price reclaim yearly open if XBI and IWM rally/bounce Downfall across the market continues--> buying between 55-80cent/share for best r:r Price target for 2023: 5-8$ What do you think ?
NASDAQ:MNMDLong
by tchatskii
ATAI short-term playHello bulls, This one is a short-term play and can't much be said about it. After CMPS crushed, price dropped to 12$ and then due to Macro economical panic, crabbed around 11$. This is good that it's crabbing around 11$ because the next steps are the slow stairs to the 15$. Volume on last hour of December 3 indicates strong interest in 10.5-11$, meaning any further panic would just keep crabbing the stock. In my opinion, if the stock doesn't close at 13$ by end of December, sell. Because it will not be a short-term swing anymore. My average is 12$, stop loss at 10$. Pros: -Exposure to ATAI assets: 400M cash, 21% stake in CMPS and it's own proper research and development pipeline -Lower the price, higher interest to invest by Dealers or keep their assets protected from too much price fluctuation downward. -Correlation to the Psychedelic sector, specifically CMPS trend. Cons: -No Revenue to backup FA, only assets. -Can't sustain price floor above 11.5$ theses last 3 weeks of bloodbath. Let's hope confidence will be coming back. -Long term not recommended since the company burns cash per quarter. Unless you are investing in speculation. Overall, ATAI resisting to the panic better than BABA. This is not a financial advise and risk should be always taken in count before trading. Take care!
NASDAQ:ATAILong
by DumpItAgain
Chillin At the 382 FibMNMD still hanging out around this 382 fib line. Wondering if the upcoming Atai IPO will help or hurt things. "Psychadelic penny stocks are performing well as many companies in the niche are growing in both size and popularity. Its latest update comes from May 26th when the company published its first pharmacogenetics data report on LSD in collaboration with Liechti Lab in Basel, Switzerland...Again, the field of psychedelics and publicly traded psychedelic stocks are both very new to investors. However, new can be good if it is done correctly. In the past month, shares of MNMD stock have risen by around 12%. And, in the past year, that number jumps to a staggering 1,143% as of June 16th." Quote Source: 4 Penny Stocks to Watch Following the Fed Meeting and Powell’s Remarks
NASDAQ:MNMD
by PennyStocks101
Pharma Patent Law Party Time!! $PHRRFSo here's my guess for the next short term bout of fun and awesome small cap volatility! Seriously though, I like how this company operates so far. Protective patents have been filed, they've already set up plenty of partnerships to get clinical trials rolling, and the blue-sky potential here is pretty staggering. No, really, it's suspiciously good. I'm obviously kinda dumb though, so it could just be a "stuck in my own thrall" kinda situation. Ok for starters, I'll admit that I don't care about the patent stuff. I'll explain why: I'm confident that the microneedle patch is protective enough that the whole issue of 'method of treatment' patents is negligible. But everyone is going to see "Clinical Trials for Big Disease! Big Yes!" Then they see it's for a generic drug and are all, "well that isn't how you print money!" and they scurry back into their dark abyss. Ok, so say it with me: " proprietary patch is patent protected." Don't worry, I'm totally gonna forget, too! But even aside from that, there is a (relatively-recent!) precedent set for patent protections in regards to "Methods of Treatment." It's a whole 'thing' that I'm not qualified to talk about, but I'm doing my own due diligence. Without looking though, I can say that a court case settled in 2018 is new by law standards, and new laws are frequently subject to challenges. For this reason, I'm gonna go ahead and anticipate a (temporary, brief) further drop in share price until everyone brushes up on the relevant patent cases. When everyone's homework gets turned in, I'm thinking we'll see $0.45USD. Idk, I really like when projected patterns line up with good fundamental markers- bonus points for ending on or near pretty, round numbers. I've gotta admit though, it's definitely feels like a stupid way to think, so it's probably dangerous to share the notion. Caveat stultus and all that. Regardless, the company still has a ridiculously small market cap when compared to other equivalent players in the psychedelic pharmaceutical space. Yeah, even after the recent gains. (To be fair, it could just mean that everyone else has much more room to fall.) Anyway! Let me know if I need to stop! :)
OTC:PHRRFLong
by pleasesendhel
MYCO - Next Move? MYCO has formed a prefect cup & handle on the daily - 4 hits against an important 0.60 resistance - handle dropped perfectly on the 0.5 fib support level - price is currently consolidating right below resistance Fundamentals in the psychedelic space are lining up perfectly for a MYCO breakout. - they are 1 in only 4 companies currently approved for phase 2 FDA trials - confirmed listing on the first ever psychedelic ETF - PSYK However, a breakout will only be confirmed after a daily close above 0.60 - volume and a newly approved catalyst will be key Good Luck to All!
CSE:MYCOLong
by LibraTradesNY
1
Ascending Triangle for BUZZ?It appears as though BUZZ is trading in a micro bullish flag outlined in light green inside of a Macro Ascending Triangle in dark blue. On the RSI it's possible we've seen a double top and an H&S may be on the verge of forming; if so the bullish flag will be negated thus resulting in a descending triangle. If that happens the blue upward sloping support of the Ascending Triangle needs to hold to see a bullish longer term outcome. On the KST there's been a bullish cross where I have the blue downward pointing finger.
BLong
by ScotianBot
3
MMED still looks like a buy before NASDAQ uplistingHello fellow bulls and future Warren Buffetts, hope you all had a good Christmas because the gift you received from MMED was a 92 Million dollars public deal, this is an extremely good news because now MMED can operate for years without worrying about debt nor the cost of operating a pharma company. This is a sign that this company can grow long term and perhaps become something big. Now, the CEO of MMED said in the interview that closing the public deal will let them work full time on the NASDAQ up-listing goal. As we can see from their perspectives, getting up-listed on NASDAQ is not an easy job. It requires a lot of time and money, which now the company got both of these resources for sure. I said last time that up-listing may be between December-January. However, the 92 millions dollars public deal announcement came out of no where and delayed the plans and decreased the stock price. My opinion, the final train is loading up before the departure and you still have time to hop in. I bought more shares when it dropped to 3.6$/share. People sell because they look for fast money, you need to give MMED some time, it already went 400% in one month. I am going to hold and speculate that between January and February, we will have some update about the NASDAQ up-listing news, we will even have a chance to grow within this time period. To the moon bois, MMED will reach 10$ when up-listing will be announced. And on the day of up-listing, people will sell their expensive CMPS shares and buy more MMED, driving it to 20$. Good luck mates!
MLong
by DumpItAgain
3
NUMI can possibly take the same path as MMEDHello fellow bulls and bag holders, December was a crazy volatile month for psychedelics penny stocks, and some of u maybe lost or won, me? I just bag hold like Warren Buffet or something. I will upload an update on MMED soon but I wanted to tell you guys that NUMI is a cheap and has the same potentials as MMED to rise. It only needs a small push from MMED with their NASDAQ up-listing announcement. There are 3 points where it can spike from because theses are the points where I predict the news about MMED up-listing will come out. If you don't understand them, then I will just say it more simple. Just bag hold NUMI, TRIP or MMED for 2 months and one of this points have a chance to spike, possibly profiting on 400% within 2 months just like MMED did. However, NUMI may be cheaper than MMED, it is certainly does not have a lot of cash to operate long term like MMED. Without the trend or public offerings, this company will get into big amounts of debts and die eventually, so ride it only for the trend and not for what they promise. Good Luck mates and to the moon!!!!!!!!!!!!!!!!!!
NLong
by DumpItAgain